FdaApplication

NDA 021299

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSEBELA IRELAND LTD
application_typeNDA
approval_date2003-07-03

Products (4)

ProductActive ingredientStrengthDosage form
PEXEVAPAROXETINE MESYLATEEQ 10MG BASETABLET;ORAL
PEXEVAPAROXETINE MESYLATEEQ 30MG BASETABLET;ORAL
PEXEVAPAROXETINE MESYLATEEQ 20MG BASETABLET;ORAL
PEXEVAPAROXETINE MESYLATEEQ 40MG BASETABLET;ORAL

4 products